Aus für appetitzügler

Zeitschrift fur Ernahrungswissenschaft

Volumn 37, Issue 1, 1998, Pages 56-58

  Muller M J ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; AMPHETAMINE; BETA ADRENERGIC RECEPTOR; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; DEXFENFLURAMINE; DISACCHARIDASE; FENFLURAMINE; FLUOXETINE; GALANIN; PHENTERMINE; PONDERAX RET; UNCLASSIFIED DRUG;

APPETITE; ARTICLE; HUMAN; OBESITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG MONITORING; NOTE; TREATMENT PLANNING;

APPETITE; APPETITE DEPRESSANTS; HUMANS; OBESITY;

EID: 0031954143     PISSN: 0044264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Centers of Disease Control and Prevention: Cardiac valvulopathy associated with exposure to Fenfluramine or Dexfenfluramine: US Department of Health Services Interim Public Health Recommendations, Nov. 1997. JAMA 278, 1729-1731., 1997
2. Arzneimittelkommission der Deutschen Ärzteschaft: Ruckruf von Ponderax(r) (Fenfluramin) und Isomeride(r) (Dexfenfluramin). Deutsches Ärzteblatt 94, C2063, 1997
3. Abenheim L, Moride Y, Brenot F, et al. (1996) Appetite supressant drugs and the risk of primary pulmonary hypertension. New Engl J Med 335: 609-616
4. Connolly HM, Crary JL, McDonn MD, et al. (1997) Valvular Heart Disease associated with fenfluramin-phentermin. New. Engl J Med 337:581-588
5. Mark EJ, Patalas ED, Chang HT et al. (1997) Fatal pulmonary hypertension associated with short term use of fenfluramine and phentermine. N Engl J Med 337:602-606
6. National task Force on the prevention and treatment of obesity: Long-term Pharmacotherapy in the management of Obesity. JAMA 276, 1907-1914, 1996
7. Manson JE, Faich GA (1996) Pharmacotherapy For Obesity - Do Benefits outweigh the Risks? New Engl J Med 335:659-660
8. Curfman GD (1997) Diet Pills Redux. New Engl J Med 337:629-630
9. Wechsler JG, Schusdziarra, Hauner H, Gries FA (1996) Therapie der Adipositas. Deutsches Ärzteblatt 93, Cl 580C1582
10. Guy-Grand B, Apfelbaum M, Crepaldi G, et al. (1989) International trial of long-term dexfenfluramin in Obesity. Lancet 2, 1142-1144
11. Weintraub M, (Ed.) (1992) Long-Term Weight Control: The National Heart, Lung, and Blood Institute Funded Multimodal Intervention Study. Clin Pharmacol Ther 51, Suppl. 581-646
12. Atkinson RL, Hubbard VS (1994) Report on the NIH Workshop on Pharmacologie Treatment of Obesity. Am J Clin Nutr 60:153-156
13. Goldstein DJ, Potvin JH (1994) Long term weight loss: The effect of pharmacologie agents. Am J Clin Nutr 60: 647-655
14. Glenny AM, O'Meara SO, Melville A, et al. (1997) The treatment and Prevention of Obesity: A systematic Review of the Literature. Intern J Obes 21 : 715-737
15. Thomas PR, (Ed.) (1995) Weighing the Options-Criteria for weight-management Programs. Nat Acad Press, Washington DC
16. Müller MJ (1997) Therapie der Adipositas-Konstruktive Anmerkungen Deutsches Ärzteblatt 94, A602
17. Müller MJ (1997) Therapie der Adipositas erfordert Umstellung der Lebensgewohnheiten. Pharmzeutische Zeitung 142:503-511